Comparison of the cardiac troponin I-cardiac troponin T-troponin C complex and cardiac troponin I and T in distinguishing myocardial infarction using a single sample at presentation
-
Ling Li
,
Xin Shu
und
Zhenlu Zhang
Abstract
Objectives
The potential relationship between cardiac troponin (cTn) composition and etiologies of myocardial injury may provide diagnostic insights for myocardial infarction (MI). We compared the performance of novel ternary cTnI–cTnT–TnC complex (ITC) assays with high-sensitivity (hs)-cTnI and hs-cTnT in differentiating MI patients at presentation.
Methods
Plasma samples from 1,210 patients with suspected MI were collected. Major cTn forms were quantified using long-cTnT ITC complex, hs-total ITC complex, hs-cTnI and hs-cTnT assay. We compared the assay performance based on the 99th percentile upper reference limits (URLs), evaluated their area under the receiver operating characteristic curve (AUC), and assessed their ability to differentiate MI using established cut-off values.
Results
A total of 138 (11.4 %) patients were diagnosed with MI. 86 % patients had long-cTnT ITC complex concentration below the 99th percentile URLs (sensitivity: 0.818, specificity: 0.943, NPV: 0.975, PPV: 0.649). AUC was 0.959 for long-cTnT ITC complex, comparable to hs-cTnI (0.953) and superior to hs-total ITC complex (0.889) and hs-cTnT (0.927). Using established cut-off values, the long-cTnT ITC complex assay classified 10 % of patients as rule-in and 52 % as rule-out (sensitivity: 0.993, NPV: 0.998, specificity: 0.972, PPV: 0.760), which was comparable to hs-cTnI and better than hs-total ITC complex and hs-cTnT. In early-presenting patients, the long-cTnT ITC complex demonstrated enhanced discrimination and improved diagnostic performance.
Conclusions
The long-cTnT ITC complex assay demonstrated performance comparable to hs-cTnI and superior to hs-total ITC complex and hs-cTnT in distinguishing MI using a single sample at presentation. These findings suggest its potential utility in improving risk stratification and triage strategies, particularly among early-presenting patients.
Funding source: Noncommunicable Chronic Diseases-National Science and Technology Major Project
Award Identifier / Grant number: 2023ZD0509500
-
Research ethics: The present study carried out at Wuhan Asia Heart hospital (Wuhan, Hubei province, China) was approved by the Ethics Committee in accordance with the Helsinki Declaration.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. Zhenlu Zhang and Yi Zhang contributed to the conception and design of the study. Ling Li and Yuqing Liu contributed to acquisition, analysis, interpretation of data and the manuscript drafting. Yu Wu, Juan Yang, Litao Zhang, Xin Shu, Hui Wang, Yisha Jing, Tongxin Ni and Liyao Gou contributed to manuscript check and modification.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has filed for the patent applications PCT/CN2023/112993, PCT/ CN2023/112994, and PCT/CN2024/112205.
-
Research funding: This study was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0509500) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Financial support was not dependent on the results of the study.
-
Data availability: On appropriate request.
References
1. Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, et al.. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:e618–51. https://doi.org/10.1161/cir.0000000000000617.Suche in Google Scholar
2. McManus, DD, Gore, J, Yarzebski, J, Spencer, F, Lessard, D, Goldberg, RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 2011;124:40–7. https://doi.org/10.1016/j.amjmed.2010.07.023.Suche in Google Scholar PubMed PubMed Central
3. Collet, JP, Thiele, H, Barbato, E, Barthelemy, O, Bauersachs, J, Bhatt, DL, et al.. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289–367. https://doi.org/10.1093/eurheartj/ehaa575.Suche in Google Scholar PubMed
4. Byrne, RA, Rossello, X, Coughlan, JJ, Barbato, E, Berry, C, Chieffo, A, et al.. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720–826. https://doi.org/10.1093/eurheartj/ehad191.Suche in Google Scholar PubMed
5. Westermann, D, Neumann, JT, Sorensen, NA, Blankenberg, S. High-sensitivity assays for troponin in patients with cardiac disease. Nat Rev Cardiol 2017;14:472–83. https://doi.org/10.1038/nrcardio.2017.48.Suche in Google Scholar PubMed
6. Januzzi, JLJr., Mahler, SA, Christenson, RH, Rymer, J, Newby, LK, Body, R, et al.. Recommendations for institutions transitioning to high-sensitivity troponin testing: JACC scientific expert panel. J Am Coll Cardiol 2019;73:1059–77. https://doi.org/10.1016/j.jacc.2018.12.046.Suche in Google Scholar PubMed
7. Katrukha, IA. Human cardiac troponin complex. Structure and functions. Biochemistry (Mosc) 2013;78:1447–65. https://doi.org/10.1134/s0006297913130063.Suche in Google Scholar PubMed
8. Marston, S, Zamora, JE. Troponin structure and function: a view of recent progress. J Muscle Res Cell Motil 2020;41:71–89. https://doi.org/10.1007/s10974-019-09513-1.Suche in Google Scholar PubMed PubMed Central
9. Katrukha, IA, Katrukha, AG. Myocardial injury and the release of troponins I and T in the blood of patients. Clin Chem 2021;67:124–30. https://doi.org/10.1093/clinchem/hvaa281.Suche in Google Scholar PubMed
10. Vylegzhanina, AV, Kogan, AE, Katrukha, IA, Koshkina, EV, Bereznikova, AV, Filatov, VL, et al.. Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction. Clin Chem 2019;65:882–92. https://doi.org/10.1373/clinchem.2018.301127.Suche in Google Scholar PubMed
11. Katrukha, IA, Riabkova, NS, Kogan, AE, Vylegzhanina, AV, Mukharyamova, KS, Bogomolova, AP, et al.. Fragmentation of human cardiac troponin T after acute myocardial infarction. Clin Chim Acta 2023;542:117281. https://doi.org/10.1016/j.cca.2023.117281.Suche in Google Scholar PubMed
12. Damen, SAJ, Cramer, GE, Dieker, HJ, Gehlmann, H, Ophuis, T, Aengevaeren, WRM, et al.. Cardiac troponin composition characterization after non ST-elevation myocardial infarction: relation with culprit artery, ischemic time window, and severity of injury. Clin Chem 2021;67:227–36. https://doi.org/10.1093/clinchem/hvaa231.Suche in Google Scholar PubMed
13. Li, L, Liu, Y, Katrukha, IA, Zhang, L, Shu, X, Xu, A, et al.. Characterization of cardiac troponin fragment composition reveals potential for differentiating etiologies of myocardial injury. Clin Chem 2025;71:396–405. https://doi.org/10.1093/clinchem/hvae200.Suche in Google Scholar PubMed
14. Li, L, Liu, Y, Katrukha, IA, Zhang, L, Shu, X, Xu, A, et al.. Design and analytical evaluation of novel cardiac troponin assays targeting multiple forms of the cardiac troponin I-cardiac troponin T-troponin C complex and fragmentation forms. Clin Chem 2025;71:387–95. https://doi.org/10.1093/clinchem/hvae182.Suche in Google Scholar PubMed
15. Li, L, Shu, X, Zhang, L, Xu, A, Yang, J, Jing, Y, et al.. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay. Clin Chem Lab Med 2024;62:353–60. https://doi.org/10.1515/cclm-2023-0529.Suche in Google Scholar PubMed
16. Mingels, AM, Cardinaels, EP, Broers, NJ, van Sleeuwen, A, Streng, AS, van Dieijen-Visser, MP, et al.. Cardiac troponin T: smaller molecules in patients with end-stage renal disease than after onset of acute myocardial infarction. Clin Chem 2017;63:683–90. https://doi.org/10.1373/clinchem.2016.261644.Suche in Google Scholar PubMed
17. Vroemen, WHM, Mezger, STP, Masotti, S, Clerico, A, Bekers, O, de Boer, D, et al.. Cardiac troponin T: only small molecules in recreational runners after marathon completion. J Appl Lab Med 2019;3:909–11. https://doi.org/10.1373/jalm.2018.027144.Suche in Google Scholar PubMed
18. Airaksinen, KEJ, Aalto, R, Hellman, T, Vasankari, T, Lahtinen, A, Wittfooth, S. Novel troponin fragmentation assay to discriminate between troponin elevations in acute myocardial infarction and end-stage renal disease. Circulation 2022;146:1408–10. https://doi.org/10.1161/circulationaha.122.060845.Suche in Google Scholar PubMed
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0385).
© 2025 Walter de Gruyter GmbH, Berlin/Boston
